biotech

"This is the first approval for TEPEZZA in Asia and marks a significant milestone for the global treatment of…
Read More...

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the United States…
Read More...